Almirall to market Merck Sharp diabetes drug (Reuters, 4 November 2008)
17 Nov 2008
The pharmaceutical company Almirall (Spain) has reached an agreement with Merck Sharp & Dohme to market its Tesavel Type 2 diabetes drug in Spain.
Full article